Dyanavel XR (Tris Pharma Inc)


Welcome to the PulseAid listing for the Dyanavel XR drug offered from Tris Pharma Inc. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Tris Pharma Inc
NON-PROPRIETARY NAME: amphetamine
SUBSTANCE NAME: AMPHETAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
ROUTE: ORAL
DOSAGE FORM: SUSPENSION, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-10-01
END MARKETING DATE: 0000-00-00


Dyanavel XR HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDyanavel XR from Tris Pharma Inc
LABELER NAME: Tris Pharma Inc
DEA SCHEDULE: CII
ACTIVE STRENGTH: 2.5(mg/mL)
START MARKETING DATE: 2015-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 27808-102_4b80fde6-331f-4ac9-a21a-1ea0f7213de2
PRODUCT NDC: 27808-102
APPLICATION NUMBER: NDA208147

Other AMPHETAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Neos Therapeutics, LPAdzenys ER
Tris Pharma IncDyanavel XR